Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Vos T, Flaxman AD, Naghavi M et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet380(9859),2163–2196 (2012).
  MedlineGoogle Scholar
• 2  Wang SJ, Chen PK, Fuh JL. Comorbidities of migraine. Front. Neurol.1,16 (2010).
  MedlineGoogle Scholar
• 3  Salomone S, Caraci F, Capasso A. Migraine: an overview. Open Neurol. J.3,64–71 (2009).
  MedlineGoogle Scholar
• 4  Lea RA, Ovcaric M, Sundholm J, Solyom L, MacMillan J, Griffiths LR. Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res. Mol. Brain Res.136(1–2),112–117 (2005).
  Medline CASGoogle Scholar
• 5  Kara I, Ozkok E, Aydin M et al. Combined effects of ACE and MMP-3 polymorphisms on migraine development. Cephalalgia27(3),235–243 (2007).
  Medline CASGoogle Scholar
• 6  Joshi G, Pradhan S, Mittal B. Role of the ACE I/D and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. J. Neurol. Sci.277(1–2),133–137 (2009).
  Medline CASGoogle Scholar
• 7  Lin JJ, Wang PJ, Chen CH, Yueh KC, Lin SZ, Harn HJ. Homozygous deletion genotype of angiotensin converting enzyme confers protection against migraine in man. Acta Neurol. Taiwan14(3),120–125 (2005).
  MedlineGoogle Scholar
• 8  Tronvik E, Stovner LJ, Bovim G et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurol.8,4 (2008).
  MedlineGoogle Scholar
• 9  Tietjen GE, Herial NA, Utley C, White L, Yerga-Woolwine S, Joe B. Association of von Willebrand factor activity with ACE I/D and MTHFR C677T polymorphisms in migraine. Cephalalgia29(9),960–968 (2009).
  Medline CASGoogle Scholar
• 10  Gard PR. Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review. Int. J. Mol. Epidemiol. Genet.1(2),145–157 (2010).▪ Provides a comprehensive review of 250 articles concerning the association of the ACE gene insertion/deletion polymorphisms and various disease conditions.
  Medline CASGoogle Scholar
• 11  Kowa H, Fusayasu E, Ijiri T et al. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci. Lett.374(2),129–131 (2005).
  Medline CASGoogle Scholar
• 12  Horasanlı B, Ataç FB, Coven I, Karakurum Goksel B, Benli S. Angiotensin I-converting enzyme gene (I/D) polymorphism in patients with migraine. Headache53(1),161–164 (2013).
  MedlineGoogle Scholar
• 13  Paterna S, Di Pasquale P, Cottone C et al. Migraine without aura and ACE-gene deletion polymorphism: is there a correlation? preliminary findings. Cardiovasc. Drugs Ther.11(4),603–604 (1997).
  Medline CASGoogle Scholar
• 14  Paterna S, Di Pasquale P, D’Angelo A et al. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur. Neurol.43(3),133–136 (2000).
  Medline CASGoogle Scholar
• 15  Alicakmak E, Cataloluk O, Yoldas T et al. Migraine and angiotensin-converting enzyme association in Turkish patients. Pain Clin.15(4),473–477 (2003).
  Google Scholar
• 16  Schurks M, Zee RY, Buring JE, Kurth T. ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology72(7),650–656 (2009).
  Medline CASGoogle Scholar
• 17  Schürks M, Rist PM, Kurth T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache50(4),588–599 (2010).▪▪ Performs a systematic review and meta-analysis on the association between ACE insertion/deletion polymorphisms and migraine.
  MedlineGoogle Scholar
• 18  Palmirotta R, Barbanti P, Ludovici G et al. Establishment of a biorepository for migraine research: the experience of interinstitutional multidisciplinary biobank (BioBIM). Neurol. Sci.34(9),1659–1663 (2013).▪▪ Provides extensive and detailed information on demographics and clinical characteristics of migraine patients recruited at the Interinstitutional Multidisciplinary BioBank – BioBIM.
  MedlineGoogle Scholar
• 19  Palmirotta R, Ludovici G, Egeo G et al. Prion protein gene M129V polymorphism and variability in age at migraine onset. Headache53(3),540–545 (2013).
  MedlineGoogle Scholar
• 20  Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd Edition. Cephalalgia24(Suppl. 1),9–160 (2004).
  MedlineGoogle Scholar
• 21  Headache Classification Committee, Olesen J, Bousser MG et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia26,742–746 (2006).
  Medline CASGoogle Scholar
• 22  Barbanti P, Fabbrini G, Aurilia C, Defazio G, Colosimo C, Berardelli A. No association between essential tremor and migraine: a case–control study. Cephalalgia30,686–689 (2010).
  MedlineGoogle Scholar
• 23  Palmirotta R, Ludovici G, De Marchis ML et al. Pre-analytical procedures for DNA studies: the experience of the interinstitutional multidisciplinary biobank (BioBIM). Biopreserv. Biobank.9(1),35–45 (2011).
  Medline CASGoogle Scholar
• 24  de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM. Molecular genetics of migraine. Hum. Genet.126(1),115–132 (2009).
  MedlineGoogle Scholar
• 25  Asghar MS, Hansen AE, Amin FM et al. Evidence for a vascular factor in migraine. Ann. Neurol.69(4),635–645 (2011).
  MedlineGoogle Scholar
• 26  Pan HL. Brain angiotensin II and synaptic transmission. Neuroscientist10(5),422–431 (2004).
  Medline CASGoogle Scholar
• 27  Dalkara T, Nozari A, Moskowitz MA. Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol.9(3),309–317 (2010).
  Medline CASGoogle Scholar
• 28  Sierra C, Coca A, Gomez-Angelats E, Poch E, Sobrino J, de la Sierra A. Renin–angiotensin system genetic polymorphisms and cerebral white matter lesions in essential hypertension. Hypertension39(2 Pt 2),343–347 (2002).
  Medline CASGoogle Scholar
• 29  Zhang Z, Xu G, Liu D, Fan X, Zhu W, Liu X. Angiotensin-converting enzyme insertion/deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case–control studies. PLoS ONE7(10),e46495 (2012).
  Medline CASGoogle Scholar
• 30  Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia30(2),129–136 (2010).
  Medline CASGoogle Scholar
• 31  Di Lorenzo CD, Coppola G, Curra A et al. Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I/D genetic polymorphism. Cephalalgia32(16),1189–1197 (2012).
  MedlineGoogle Scholar
• 32  Barbanti P, Aurilia C, Egeo G, Fofi L. Migraine prophylaxis: what is new and what we need? Neurol. Sci.32(Suppl. 1),S111–S115 (2011).▪▪ Provides an extensive discussion on conventional and emerging treatments for migraine prophylaxis.
  MedlineGoogle Scholar
• 33  Diener HC, Gendolla A, Feuersenger A et al. Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial. Cephalalgia29(9),921–927 (2009).
  Medline CASGoogle Scholar
• 34  Schuh-Hofer S, Flach U, Meisel A, Israel H, Reuter U, Arnold G. Efficacy of lisinopril in migraine prophylaxis – an open label study. Eur. J. Neurol.14(6),701–703 (2007).
  Medline CASGoogle Scholar
• 35  Sonbolestan SA, Heshmat K, Javanmard SH, Saadatnia M. Efficacy of enalapril in migraine prophylaxis: a randomized, double-blind, placebo-controlled trial. Int. J. Prev. Med.4(1),72–77 (2013).
  MedlineGoogle Scholar
• 36  Nandha R, Singh H. Renin angiotensin system: a novel target for migraine prophylaxis. Indian J. Pharmacol.44(2),157–160 (2012).
  Medline CASGoogle Scholar
• 37  Allen AM, Moeller I, Jenkins TA et al. Angiotensin receptors in the nervous system. Brain Res. Bull.47(1),17–28 (1998).
  Medline CASGoogle Scholar
• 101  Interinstitutional Multidisciplinary BioBank (BioBIM) www.sanraffaele.it/contenuti/reparti/30/biobanca-interistituzionale-multidisciplinare
  Google Scholar
• 102  Institut Català d’Oncologia: SNPStats http://bioinfo.iconcologia.net/snpstats/start.htm
  Google Scholar